142 related articles for article (PubMed ID: 31659493)
1. Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals.
de Blois E; de Zanger RMS; Chan HS; Konijnenberg M; Breeman WAP
EJNMMI Radiopharm Chem; 2019 Jan; 4(1):3. PubMed ID: 31659493
[TBL] [Abstract][Full Text] [Related]
2. A Specific HPLC Method to Determine Residual HEPES in [
Migliari S; Scarlattei M; Baldari G; Silva C; Ruffini L
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889351
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [
Hooijman EL; Ntihabose CM; Reuvers TGA; Nonnekens J; Aalbersberg EA; van de Merbel JRJP; Huijmans JE; Koolen SLW; Hendrikx JJMA; de Blois E
EJNMMI Radiopharm Chem; 2022 Nov; 7(1):29. PubMed ID: 36333648
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of Analytical Methods for Radiochemical Purity of
Orhon P; Desruet MD; Piquemal M; De Leiris N; Djaileb L; Vuillez JP; Bedouch P; Leenhardt J
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631349
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Validation of Quality Control Parameters of Cassette-Based Gallium-68-DOTA-Tyr3-Octreotate Synthesis.
Sammartano A; Migliari S; Scarlattei M; Baldari G; Ruffini L
Indian J Nucl Med; 2020; 35(4):291-298. PubMed ID: 33642752
[TBL] [Abstract][Full Text] [Related]
7. A suitable time point for quantifying the radiochemical purity of
Kelly JM; Amor-Coarasa A; Sweeney E; Wilson JJ; Causey PW; Babich JW
EJNMMI Radiopharm Chem; 2021 Dec; 6(1):38. PubMed ID: 34928478
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of quenchers to reduce radiolysis of (111)In- or (177)Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC.
de Blois E; Chan HS; Konijnenberg M; de Zanger R; Breeman WA
Curr Top Med Chem; 2012; 12(23):2677-85. PubMed ID: 23339763
[TBL] [Abstract][Full Text] [Related]
9. Improved quality control of [
Kraihammer M; Garnuszek P; Bauman A; Maurin M; Alejandre Lafont M; Haubner R; von Guggenberg E; Gabriel M; Decristoforo C
EJNMMI Radiopharm Chem; 2023 Mar; 8(1):7. PubMed ID: 36971890
[TBL] [Abstract][Full Text] [Related]
10. Novel developed HPLC analyses of [
Eryilmaz K; Bakar HE; Kilbas B
J Labelled Comp Radiopharm; 2022 Jun; 65(7):178-186. PubMed ID: 35466456
[TBL] [Abstract][Full Text] [Related]
11. Validation of HPLC method for the determination of chemical andradiochemical purity of a
UĞur A; ElÇİ ŞG; YÜksel D
Turk J Chem; 2021; 45(1):26-34. PubMed ID: 33679149
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a GMP-Compliant High-Pressure Liquid Chromatography Method for the Determination of the Chemical and Radiochemical Purity of [
Katzschmann I; Marx H; Kopka K; Hennrich U
Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669095
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a High-Pressure Liquid Chromatography Method for the Determination of Chemical Purity and Radiochemical Purity of a [
Migliari S; Sammartano A; Scarlattei M; Serreli G; Ghetti C; Cidda C; Baldari G; Ortenzia O; Ruffini L
ACS Omega; 2017 Oct; 2(10):7120-7126. PubMed ID: 29520394
[No Abstract] [Full Text] [Related]
14. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
15. New sensitive method for HEPES quantification in
Antunes IF; Franssen GM; Zijlma R; Laverman P; Boersma HH; Elsinga PH
EJNMMI Radiopharm Chem; 2020 May; 5(1):12. PubMed ID: 32410136
[TBL] [Abstract][Full Text] [Related]
16. Quality control on radiochemical purity in Technetium-99m radiopharmaceuticals labelling: three years of experience on 2280 procedures.
Maioli C; Luciniani G; Strinchini A; Tagliabue L; Del Sole A
Acta Biomed; 2017 Apr; 88(1):49-56. PubMed ID: 28467334
[TBL] [Abstract][Full Text] [Related]
17. An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution.
Iudicello A; Genovese F; Di Iorio V; Cicoria G; Boschi S
EJNMMI Radiopharm Chem; 2021 Mar; 6(1):14. PubMed ID: 33761040
[TBL] [Abstract][Full Text] [Related]
18. Validation of HPLC and TLC analytical methods to determine radiochemical purity of
Mutin J; Orhon P; Choisnard L; Lassiaz M; Bacot S; Ahmadi M; De Leiris N; Djaileb L; Broisat A; Ghezzi C; Bedouch P; Brunet MD; Leenhardt J
J Pharm Biomed Anal; 2024 Aug; 246():116224. PubMed ID: 38759321
[TBL] [Abstract][Full Text] [Related]
19. Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticals.
Martin S; Wendlinger L; Litvinenko A; Faizova R; Schottelius M
EJNMMI Radiopharm Chem; 2024 Mar; 9(1):23. PubMed ID: 38512591
[TBL] [Abstract][Full Text] [Related]
20. Validation of an alternative radiochemical purity method for [99mTc]pentetate ([99mTc]DTPA).
Borré MC; Tesán FC; Leonardi NM; Zubillaga MB; Salgueiro MJ
Appl Radiat Isot; 2013 Dec; 82():322-4. PubMed ID: 24140984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
